The FDA warns people to stop using LuSys COVID-19 tests

By John Munsell,Chief Executive Officer, Bizzuka

The U.S. Food and Drug Administration (FDA) is warning people to stop using the LuSys Laboratories COVID-19 Antigen Test (Nasal/Saliva) as well as the LuSys Laboratories COVID-19 IgG/IgM Antibody Test.

The performance of these tests has not been adequately established and the FDA believes there is likely a high risk of false results when using these tests. Neither test has been authorized, cleared, or approved by the FDA for distribution or use in the United States.

The LuSys Laboratories COVID-19 Antigen Tests (Nasal/Saliva) and COVID-19 IgG/IgM Antibody Tests may also be sold under the company names Luscient Diagnostics or Vivera Pharmaceuticals, or with the trade name EagleDx. The FDA believes that these tests were distributed for use in laboratories or for at-home testing.

Read more here...


FREE WEBINAR

The Immunity Score

THE Critical Metric for Keeping People Safe in the Workplace